National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 36565 [2012-14925]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 118 / Tuesday, June 19, 2012 / Notices
notify the Contact Person listed below
in advance of the meeting.
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: President’s Cancer
Panel.
Date: July 24, 2012.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: HPV Vaccination as a Model
Cancer Prevention Method: State of the,
Science and Evidence.
Place: Hilton San Francisco Financial
District, 750 Kearny Street, San Francisco,
CA 94108.
Contact Person: Abby B. Sandler, Ph.D.,
Executive Secretary, Chief, Institute Review
Office, Office of the Director, 6116 Executive
Blvd., Suite 220, MSC 8349, National Cancer
Institute, NIH, Bethesda, MD 20892–8349,
(301) 451–9399, sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Conference Grant Review.
Date: July 10–11, 2012.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael P Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–496–9659,
reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–14926 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
srobinson on DSK4SPTVN1PROD with NOTICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Mar<15>2010
16:39 Jun 18, 2012
Jkt 226001
Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–14925 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Autism
Coordinating Committee (IACC)
meeting.
The purpose of the IACC meeting is
for the Secretary of Health and Human
Services to welcome new members of
the committee and thank previous
members for their service. The meeting
will include presentations from
stakeholders on autism research and
policy issues, as well as discussion
around newly released IACC documents
and plans for future committee
activities. The meeting will be open to
the public and accessible by live
webcast and conference call.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of meeting: Open Meeting.
Date: July 10, 2012.
Time: 9:00 a.m. to 5:00 p.m. *Eastern
Time*—Approximate end time.
Agenda: The Secretary of HHS will
welcome new members of the committee and
thank previous members for their service.
The meeting will include presentations on
autism research and policy issues, and the
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
36565
committee will discuss plans for future
activities.
Place: L’Enfant Plaza Hotel, 408 L’Enfant
Plaza, SW., Washington, DC 20024.
Conference Call: Dial: 888–455–5419,
Access code: 9404105.
Cost: The meeting is free and open to the
public.
Webcast Live: https://videocast.nih.gov/.
Registration: https://
www.acclaroresearch.com/oarc/7-10-12/.
Pre-registration is recommended to expedite
check-in. Seating in the meeting room is
limited to room capacity and on a first come,
first served basis.
Deadlines: Notification of intent to present
oral comments: Tuesday, July 3, 2012 by 5:00
p.m. ET Submission of written/electronic
statement for oral comments: Thursday, July
5, 2012 by 5:00 p.m. ET Submission of
written comments: Thursday, July 5, 2012 by
5:00 p.m. ET.
Access: (L’Enfant Plaza Metro) Orange,
Blue, Yellow, and Green Lines.
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, NSC, Room 6182A,
Rockville, MD 20852, Phone: (301) 443–6040,
Email: IACCPublicInquiries@mail.nih.gov.
Please Note: Any member of the public
interested in presenting oral comments to the
Committee must notify the Contact Person
listed on this notice by 5:00 p.m. ET on
Tuesday, July 3, 2012, with their request to
present oral comments at the meeting.
Interested individuals and representatives of
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5:00 p.m. ET on
Thursday, July 5, 2012.
Statements submitted will become a part of
the public record. Only one representative of
an organization will be allowed to present
oral comments on behalf of that organization,
and presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will be
assigned a time to speak in the order of the
date and time when their request to speak is
received, along with the required submission
of the written/electronic statement by the
specified deadline. If special
accommodations are needed, please email
the Contact Person listed above.
In addition, any interested person may
submit written comments to the IACC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET, Thursday, July 5, 2012. The
comments should include the name and,
when applicable, the business or professional
affiliation of the interested person. All
written comments received by the deadlines
for both oral and written public comments
will be provided to the IACC for their
consideration and will become part of the
public record. The meeting will be open to
the public through a conference call phone
number and webcast live on the Internet.
Members of the public who participate using
the conference call phone number will be
able to listen to the meeting but will not be
heard. If you experience any technical
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 77, Number 118 (Tuesday, June 19, 2012)]
[Notices]
[Page 36565]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14925]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Conference Grant Review.
Date: July 10-11, 2012.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Michael P Reilly, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7200, Bethesda, MD
20892, 301-496-9659, reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-14925 Filed 6-18-12; 8:45 am]
BILLING CODE 4140-01-P
